Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (IMLFF)

Inmed Pharmaceuticals Inc (IMLFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
Trade IMLFF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.0400 +60.53%
on 10/15/20
8.9400 -45.41%
on 11/09/20
+1.5300 (+45.67%)
since 10/09/20
3-Month
3.0400 +60.53%
on 10/15/20
8.9400 -45.41%
on 11/09/20
-0.2058 (-4.05%)
since 08/11/20
52-Week
3.0400 +60.53%
on 10/15/20
10.6260 -54.07%
on 01/21/20
-2.5615 (-34.42%)
since 11/11/19

Most Recent Stories

More News
InMed to Present at Virtual Conferences in March 2021

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates targeting diseases with high unmet medical...

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)
InMed Pharmaceuticals (INM): Phase II Enrolment to Begin in Second Half

LONDON, UK / ACCESSWIRE / February 22, 2021 / Following the safety and tolerability data from the two Phase I trials in healthy volunteers, INM-755 is moving forward into a Phase II (755-201-EB) trial...

IMLFF : 4.8800 (-1.61%)
InMed Announces Closing of US$4.5 Million Private Placement

, 2021 /PRNewswire/ -  ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the...

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)
InMed Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 11, 2021 / InMed Pharmaceuticals, Inc. (TSX:IN) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 11, 2021...

IMLFF : 4.8800 (-1.61%)
IN.TO : 4.12 (-10.43%)
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results

, /PRNewswire/ -  ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way...

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results

, /PRNewswire/ - ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way...

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)
IIROC Trade Resumption - IN

IIROC Trade Resumption - IN

IMLFF : 4.8800 (-1.61%)
IIROC Trading Halt - IN

IIROC Trading Halt - IN

IMLFF : 4.8800 (-1.61%)
InMed Announces US$4.5 Million Private Placement

, /PRNewswire/ - ("InMed" or the "Company") (Nasdaq:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical...

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

IMLFF : 4.8800 (-1.61%)
INM : 3.30 (-9.09%)
IN.TO : 4.12 (-10.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 5.6179
1st Resistance Point 5.2489
Last Price 4.8800
1st Support Level 4.2055
2nd Support Level 3.5311
3rd Support Level N/A

See More

52-Week High 10.6260
Fibonacci 61.8% 7.7281
Fibonacci 50% 6.8330
Fibonacci 38.2% 5.9379
Last Price 4.8800
52-Week Low 3.0400

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar